Procaps Group SA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: LU2376511205
USD
0.03
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Procaps Group SA stock-summary
stock-summary
Procaps Group SA
Pharmaceuticals & Biotechnology
Union Acquisition Corp. II is a blank check company. The Company is formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities. It intends to focus on business located in Latin America. It is focused on businesses in sectors, such as natural resources, industrial operations and financial services and technology sectors. It is not engaged in any operations nor generated any revenues.
Company Coordinates stock-summary
Company Details
1425 BRICKELL AVE, #57B , MIAMI FL : 33131
stock-summary
Tel: 1 212 9810630
stock-summary
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 2 Schemes (0.13%)

Foreign Institutions

Held by 22 Foreign Institutions (0.83%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
111 Million
(Quarterly Results - Dec 2023)
Net Profit:
-1 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 2,972 Million ()

stock-summary
P/E

5.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

252.18

stock-summary
Return on Equity

2,226.99%

stock-summary
Price to Book

2,972.29